Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

D-myo-Inositol 1,4,5-trisphosphate [Ins(1,4,5)P,] is a well established, Ca2+-releasing, biological second messenger. Our aim has been to radically redesign the Ins(1,4,5)P3molecule to explore whether ring-contracted and carbohydrate-based mimics might be feasible targets for development of novel ligands for pharmacological intervention in the polyphosphoinositide pathway of cellular signaling. We have primarily employed two approaches: first, the use of carbohydrates as chiral starting materials for synthesis of cyclopentane-based Ins(1,4,5)P3mimics using ring-contraction methodologies; second, the design of mono- and disaccharide based polyphosphates both de novo and based upon the novel hyperagonist adenophostin A, which is more potent than the natural messenger itself, as novel Ins(1,4,5)P3receptor ligands. Our studies demonstrate that both approaches possess great potential to produce highly active mimics of this fundamental second messenger.


Journal article


ACS Symposium Series

Publication Date





158 - 179